South Africa / Aspen Inks Deal to Manufacture J&J’s COVID-19 Vaccine
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
OmniMed
Last updated: 13.02.2014
Address: 7 Malibongwe Drive
Fontainebleau, Randburg
Gauteng,South Africa
Tel: + 27 11 792-7120
Web: http://www.omnimed.co.za/
Company description
OmniMed (Pty) Ltd was founded in 1960 and its main activity was the manufacture of sterile intravenous solutions under license to a leading German manufacturer. The name of the Company at the time was Remedia Medical.
In time, the Company diversified into other forms of pharmaceutical manufacture but as it evolved, it embarked upon new ventures focusing on the hospital and specialist doctor market. It acquired new licenses offering a broad spectrum of hospital consumables and equipment.
Today OmniMed owes its diversity to its ability to adapt to changing markets. Due to its long-standing presence in the market, leading product portfolio and strong customer service, OmniMed is well known in both the Private and Public Health Care sectors.
Products and services
Life-saving technologies, as well as products that improve the quality of life have always been the trademark of OmniMed.
OmniMed also provides administration and distribution services to BioMerieux SA a leading French Diagnostic company on a fee for service basis.
The manufacturing operation is located in Johannesburg and OmniMed has a fully owned well-established subsidiary in Namibia.
Related
Opinion / Malaria Prevention Cannot be Allowed to Stall During the COVID-19 Pandemic
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
News Roundup / South Africa Pharma June 2020
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a…
Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when…
Medical Device Segment braced for change in South Africa
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device…
Tackling South Africa’s “Intimate Healthcare” Needs
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it…
South African Clinical Trials: Turning Diversity into Opportunity
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease…
Showcasing South African innovation
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem…
Interview: Andre Buhrlen – Managing Director, Hersol Manufacturing…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract…
Interview: Albert Denoon – Owner, Baroque Medical, – Board Member,…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit…
Interview: Charl De Klerk – General Manager, Bard South Africa
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa…
